|
|
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma
|
| Link ID |
2444 |
| Title |
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma |
| Url |
http://www.medscape.com/viewarticle/568860?src=rss |
| Description |
Thirty of 36 patients with advanced AIDS-related Kaposi sarcoma treated with cyclical pegylated liposomal doxorubicin plus interleukin-12 (IL-12) had a major response to treatment, according to investigators at the National Cancer Institute in Bethesda, Maryland. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Jan 16, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
Simple Clinical Score Predicts Tuberculosis in HIV-Positive Children
|
|
|
A scoring scale based on readily available clinical information can help diagnose tuberculosis in HIV-positive children in rural areas, researchers from Rwanda reported recently at the annual meeting of the European Society for Paediatric Infectious Diseases held in Graz, Austria. Reuters Health Information
|
| 2. |
Memantine May Benefit Cognitively Impaired AIDS Patients
|
|
|
Memantine, an uncompetitive antagonist of the N-methyl-D-aspartate receptor, might ameliorate HIV-associated cognitive impairment, researchers report. Although their 16-week study showed no clear clinical benefit, possible neuroprotective action was demonstrated by proton magnetic resonance spectroscopy (MRS). Reuters Health Information
|
| 5. |
Heterosexual Infectivity of HIV Underestimated
|
|
|
The heterosexual infectivity of HIV-1 is commonly cited as a fixed value of approximately one transmission per 1000 sexual contacts. However, depending on the presence of several risk factors, the rate of transmission may be several hundred times higher, according to research presented Monday at the International AIDS Conference in Mexico City and published online on August 5 by The Lancet Infectious Diseases. Reuters Health Information
|
|
|